Literature DB >> 9677806

[Incidence of CIN in HIV-positive women].

R Zarcone1, P Bellini, E Carfora, M Longo, M Monarca, G Tomasillo, R Lizza.   

Abstract

BACKGROUND: The aim of this study was to evaluate the incidence of CIN in HIV-seropositive women.
METHODS: A group of 23 women with a mean age of 28 years was recluted. Three of them were clinically affected, and 20 were non-AIDS HIV-seropositive. The patients underwent cervical cytology, colposcopically directed biopsy and T-cell studies. In addition, HPV using the in vitro hybridization, was investigated.
RESULTS: Eight of 23 patients (24.78%) had CIN. Patients with CIN had significantly lower CD4 cell counts and CD4/CD8 ratios than those without CIN. Patients with AIDS had higher grade lesions than those non-AIDS HIV-sero-positive.
CONCLUSIONS: The data obtained suggest that abnormal cervical pathology is common among HIV seropositive women, and so cervical colposcopy should be part of the routine management of HIV-seropositive women.

Entities:  

Mesh:

Year:  1998        PMID: 9677806

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  4 in total

1.  Infection and cervical neoplasia: facts and fiction.

Authors:  Wael I Al-Daraji; John Hf Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-04-28

Review 2.  Pregnancy in HIV-positive patients: effects on vaginal flora.

Authors:  Cristina Vallone; Giuliano Rigon; Valeria Lucantoni; Lorenza Putignani; Fabrizio Signore
Journal:  Infect Dis Obstet Gynecol       Date:  2012-05-17

3.  Gynaecological morbidity among HIV positive pregnant women in Cameroon.

Authors:  Enow R Mbu; Eugene J Kongnyuy; F X Mbopi-Keou; Rebecca N Tonye; Philip N Nana; Robert J I Leke
Journal:  Reprod Health       Date:  2008-07-03       Impact factor: 3.223

4.  Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects.

Authors:  Debora Mondatore; Francesca Bai; Matteo Augello; Marco Giovenzana; Andrea Pisani Ceretti; Valeria Bono; Enrico Opocher; Antonella d'Arminio Monforte; Giulia Carla Marchetti; Camilla Tincati
Journal:  Open Forum Infect Dis       Date:  2022-01-30       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.